Eph-Ephrin Bidirectional Signaling in Physiology and Disease

Slides:



Advertisements
Similar presentations
Signal Transduction II Transduction Proteins & Second Messengers.
Advertisements

Eph-Ephrin Bidirectional Signaling in Physiology and Disease Elena B. Pasquale Cell Volume 133, Issue 1, Pages (April 2008) DOI: /j.cell
Model for regulation of the Ras p21 product and for the GTPase-activating protein (GAP) as a downstream effector and regulator of ras activity. Ras is.
Cell Signaling Pathways – A Case Study Approach
Briefly explain the location of the cellular receptor and the mechanism of action of steroid hormones. Distinguish between synaptic, paracrine, and endocrine.
OVERVIEW: Signals for cell surface receptors (hydrophilic):
Sustaining Proliferative Signaling and Evading Growth Suppressors
Chap. 16 Problem 1 Cytokine receptors and RTKs both form functional dimers on binding of ligand. Ligand binding activates cytosolic kinase domains which.
Ambiguous Origin: Two Sides of an Ephrin Receptor Tyrosine Kinase
You have identified a novel cytoplasmic protein
Signal Transduction Through the Epidermal Growth Factor Receptor
Signaling molecules as therapeutic targets in allergic diseases
Volume 73, Issue 5, Pages (March 2008)
Some examples of how NMR can provide information about biological systems.
C2 Can Do It, Too Cell Volume 121, Issue 2, Pages (April 2005)
Fixing a Hole Where the Ras Gets In
Cell Signaling by Receptor Tyrosine Kinases
Should I Stay or Should I Go: Neuromodulators of Behavioral States
Tiki Casts a Spell on Wnt
Gonadotropin Signaling in the Ovary
An Uncommon Tail about the Common γ-Chain
EGFR T790M Mutation: A Double Role in Lung Cancer Cell Survival?
Volume 72, Issue 1, Pages 9-21 (October 2011)
Great Expectations for PIP: Phosphoinositides as Regulators of Signaling During Development and Disease  Lara C. Skwarek, Gabrielle L. Boulianne  Developmental.
Designing New Cellular Signaling Pathways
PTEN Enters the Nuclear Age
Volume 46, Issue 5, Pages (June 2012)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Epigenetics Drives RAGs to Recombination Riches
Vascular Endothelial Growth Factor (VEGF) Pathway
From ER to Eph Receptors: New Roles for VAP Fragments
Selective Insulin and Leptin Resistance in Metabolic Disorders
Signaling Interplay in Ras Superfamily Function
RalGDS comes of age Cancer Cell
Live Longer sans the AT1A Receptor
Signal Transduction: RABGEF1 Fingers RAS for Ubiquitination
The RAS/MAPK Axis Gets Stressed Out
AKT/PKB Signaling: Navigating the Network
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
Signal Transduction Through the Epidermal Growth Factor Receptor
AKT/PKB Signaling: Navigating Downstream
Signaling Networks Cell
p38δ and PKD1: Kinase Switches for Insulin Secretion
Molecular mechanisms of IgE regulation
Autosomal dominant polycystic kidney disease: the last 3 years
No Bones About It: Insulin Modulates Skeletal Remodeling
Signalling links in the liver: Knitting SOCS with fat and inflammation
Ephs and ephrins Current Biology
Conspiracy Theory Cell
Boning up on Ephrin Signaling
Amino Acid Signaling to TOR Activation: Vam6 Functioning as a Gtr1 GEF
Signaling Takes Shape in the Immune System
Volume 129, Issue 2, Pages (April 2007)
Insider Influence on ErbB Activity
Irina Dudanova, Rüdiger Klein  Neuron 
Platelet-derived growth factor (PDGF) signalling pathway.
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Intercellular Networks Underlying Developmental Decisions
Intracellular Signaling
Volume 104, Issue 4, Pages (February 2001)
Mutant BRAF Melanomas—Dependence and Resistance
Role reversal: Brain insulin and liver STAT3
Guilty as charged Cancer Cell
Discovery of a Secreted Tumor Suppressor Provides a Promising Therapeutic Strategy for Follicular Lymphoma  Marc R. Mansour, A. Thomas Look  Cancer Cell 
Ras and Rho GTPases Cell
Rho and Rac Take Center Stage
Brief Review – Growth Factors and Receptors
Tenets of PTEN Tumor Suppression
Cell Signaling by Receptor Tyrosine Kinases
Characterization of the MM.1 human multiple myeloma (MM) cell lines
Presentation transcript:

Eph-Ephrin Bidirectional Signaling in Physiology and Disease Elena B. Pasquale  Cell  Volume 133, Issue 1, Pages 38-52 (April 2008) DOI: 10.1016/j.cell.2008.03.011 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 Eph Receptor-Ephrin Bidirectional Pathways Regulate GTPases (A) Regulation of Ras GTPases. (B) Regulation of Rho GTPases. The domain structure of an Eph receptor is shown schematically, including from the N terminus: ephrin-binding domain, cystein-rich region, two fibronectin type III domains, transmembrane segment, juxtamembrane domain, kinase domain, SAM domain, and PDZ domain-binding site. The domain structure of an ephrin-B ligand is also shown, including the Eph-binding domain, linker region, transmembrane segment, cytoplasmic region, and PDZ domain-binding site. The pathways shown have been characterized with one or several Eph receptors/ephrins. For example, in (A) Shp2 has been linked to EphA2; Shc-Grb2 to EphA2 and EphB1; Cas-Rap1 to EphB1; and SPAR/E6TP1 to EphA4 and EphA6. In (B), α2-chimaerin has been linked to EphA4; FAK to EphA2 and EphB2; Ship2 to EphA2; Abl-Crk to EphB4; Ephexin family members to EphA receptors; and Kalirin, Tiam1, and Intersectin to EphB receptors. Tyrosine phosphorylation is shown only for some effectors where it has a demonstrated role in Eph-ephrin bidirectional signaling. The location of the arrows does not imply the involvement of a particular Eph or ephrin domain. The relative activation of different pathways and their effects on cell behavior may depend on the ephrin levels, degree of receptor clustering, and cellular context. The question marks indicate signaling connections that have not been conclusively demonstrated downstream of Eph receptors or ephrins. PIP3, phosphatidylinositol (3,4,5) phosphate; GEF, guanine nucleotide exchange factor; LMW-PTP, low-molecular-weight phosphotyrosine phosphatase. Cell 2008 133, 38-52DOI: (10.1016/j.cell.2008.03.011) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 2 Crosstalk between Eph-Ephrins and Other Receptors Some forms of crosstalk occur at epithelial cell junctions, others have been reported in neurons and other cell types. RTK, receptor tyrosine kinase; yellow circles, tyrosine phosphorylation; the scissors indicate proteolytic cleavage. Cell 2008 133, 38-52DOI: (10.1016/j.cell.2008.03.011) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 3 EphA-Ephrin-A Bidirectional Signaling and Insulin Secretion When glucose levels are low, forward signaling predominates inhibiting insulin secretion; when glucose levels are high, reverse signaling predominates promoting insulin secretion. Ephrin-A molecules are mainly on the cell surface whereas Eph receptor molecules are also in the secretory granules. Thicker lines indicate stronger signals; yellow circles, tyrosine phosphorylation. Cell 2008 133, 38-52DOI: (10.1016/j.cell.2008.03.011) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 4 EphB-Ephrin-B Bidirectional Signaling in Bone Formation Osteoblasts secrete cytokines that upregulate ephrin-B2 in osteoclast precursors. Ephrin-B ligands in osteoclasts interact with EphB receptors in osteoblasts generating bidirectional signals that inhibit osteoclast differentiation and promote osteoblast differentiation. Cell 2008 133, 38-52DOI: (10.1016/j.cell.2008.03.011) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 5 EphA2, Cell-Cycle Arrest, and Cellular Senescence Raf-activating mutations upregulate the levels of EphA2, which may contribute to cell-cycle arrest and senescence through inhibition of H-Ras-PI3 kinase-Akt. In cells without activated Raf, EphA2 also inhibits the MAP kinase pathway. Cell 2008 133, 38-52DOI: (10.1016/j.cell.2008.03.011) Copyright © 2008 Elsevier Inc. Terms and Conditions